Naina Rao

Naina Rao

Auto-generated profile, based on publicly available information

Naina Rao

Department of Orthopedic Surgery, New York University Langone Health, New York, New York, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2023 in Current Reviews in Musculoskeletal Medicine
Verified
Journal Article
Closed access
PDF file
JTJairo Triana
Jairo Triana
ZLZachary I Li
Zachary I Li
NRNaina Rao
Naina Rao
MKMatthew T Kingery
Matthew T Kingery
ESEric J. Strauss
Eric J. Strauss

21 July 2025 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
ISIan Savage-Elliott
Ian Savage-Elliott
ZLZachary I Li
Zachary I Li
NRNaina Rao
Naina Rao
JTJairo Triana
Jairo Triana
SGSharif Garra
Sharif Garra
LJLaith M. Jazrawi
Laith M. Jazrawi
Background: The utility and safety of patient-specific cutting guides (PSCGs) in osteotomies about the knee is uncertain. Purpose: To compare the cost, accuracy of radiographic correction, and safety of PSCG versus standard cutting guide (SCG) corrective osteotomies about the knee. Study Design: Cohort study; Level of evidence, 3. Methods: Patients undergoing high tibial osteotomy (HTO) or distal femoral osteotomy (DFO) were retrospectively reviewed from 2017 to 2022. Those who underwent 3-dimensional PSCG osteotomy were propensity matched to patients undergoing traditional osteotomies. Procedure time and fluoroscopic details were extracted from operative notes. Hip-knee-ankle (HKA) angle, posterior tibial slope (PTS), and mechanical axis deviation were measured on pre- and postoperative radiographs. Intraclass correlation coefficients were calculated to determine the reliability between the intended and resultant correction of HKA. Time-driven activity-based costing (TDABC) analysis was performed to compare procedure costs. Results: A total of 42 patients were included, with 11 HTOs and 10 DFOs in each group. Between the SCG and PSCG groups, respectively, final HKA (2.7° vs 1.9°; P = .36), PTS (9.6° vs 9.0°; P = .79), and mechanical axis deviation (10.2 vs 5.8 mm; P = .21) were similar. The intraclass correlation coefficient between the intended and measured HKA correction was 0.841 (good) in the PSCG group and 0.623 (moderate) in the SCG group. PSCG osteotomies had a mean procedure time that was 18.5 minutes shorter than SCG osteotomies ( P = .39). Fluoroscopy time (43 vs 99 seconds; P < .001), tourniquet time (99.9 vs 116.6; P = .12), and radiation dose (2.9 vs 7.8 mGy; P = .01) were lower in the PSCG group. TDABC analysis demonstrated a total cost of $27,026 for PSCG and $27,100 for SCG. The rate of hinge fractures (9.5% vs 33.3%) and return to the operating room (4.8% vs 19.0%) were lower in the PSCG group, although these differences were nonsignificant. Conclusion: Both traditionally guided osteotomies and PSCG-guided osteotomies accurately corrected lower extremity malalignment. Utilization of PSCG resulted in similar procedure times and cost, as well as less fluoroscopy and lower tourniquet time, compared with conventional osteotomy. PSCG trended toward a decreased rate of postoperative complications.

1 May 2025 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
NRNaina Rao
Naina Rao
JTJairo Triana
Jairo Triana
AAAmanda Avila
Amanda Avila
KCKirk A. Campbell
Kirk A. Campbell
MAMichael J. Alaia
Michael J. Alaia
ESEric J. Strauss
Eric J. Strauss
Background: Efforts to decrease pain, improve early rehabilitation, and reduce opioid consumption have prompted a focus on peripheral nerve blocks for pain management after anterior cruciate ligament reconstruction (ACLR). The commonly used adductor canal block (ACB) might not provide sufficient postoperative pain control because of its lack of coverage of the posterior aspect of the knee. The addition of the IPACK (interspace between the popliteal artery and the capsule of the posterior knee) block, which targets this area, to the standard ACB could potentially provide better pain control after ACLR over the current standard of care. Purpose/Hypothesis: The purpose of this study was to compare and analyze postoperative pain, satisfaction, and opioid demand between the standard ACB and a combination of an ACB and IPACK block in patients undergoing ACLR with a bone–patellar tendon–bone (BTB) autograft. It was hypothesized was that the addition of the IPACK block would substantially improve early postoperative pain control and minimize opioid use. Study Design: Randomized controlled trial; Level of evidence, 2. Methods: A total of 102 patients undergoing ACLR with a BTB autograft at a single institution were recruited. Patients were randomly assigned to receive either the ACB alone or the ACB plus IPACK block. Patients were contacted at 24 hours (postoperative day [POD] 1), 48 hours (POD 2), 72 hours (POD 3), and 1 week to assess postoperative pain scores, opioid consumption, and satisfaction with their postoperative pain control. Intergroup comparative analysis was performed using a t test or nonparametric test for continuous variables and the chi-square test for categorical variables. Opioid usage was reported as morphine milligram equivalents (MME). Results: The final analysis included 96 patients, with 47 in the control group (ACB) who received only the ACB and 49 in the experimental group (IPACK) who received the ACB and an additional IPACK block. The cohort was composed of 60.4% male patients with a mean age of 28.40 ± 7.51 years (range, 18-55 years) and a mean body mass index of 25.67 ± 4.84 kg/m 2 . There were no statistically significant differences between the groups with respect to age, body mass index, or sex ( P > .05). Patients in the IPACK group reported significantly lower opioid usage than those in the ACB group on POD 1 (mean, 6.1 [interquartile range (IQR), 4.5-7.7] vs 10.7 [IQR, 8.6-13.0] MME, respectively; P < .001), POD 2 (mean, 7.3 [IQR, 5.2-9.5] vs 12.5 [IQR, 10.0-15.0] MME, respectively; P = .001), and POD 3 (mean, 4.2 [IQR, 2.8-5.5] vs 9.4 [IQR, 7.1-12.0] MME, respectively; P < .001). The visual analog scale for pain score on POD 1 (mean, 67.7 [IQR, 62.0-73.0] vs 55.2 [IQR, 48.0-63.0], respectively; P = .024) and POD 3 (mean, 54.9 [IQR, 48.0-63.0] vs 44.4 [IQR, 37.0-51.0], respectively; P = .037) was statistically higher in the ACB group compared with the IPACK group. On POD 1, patient satisfaction was higher in the IPACK group than in the ACB group (mean, 7.3 [IQR, 6.6-8.0] vs 5.6 [IQR, 4.8-6.4], respectively; P = .001). No statistically significant differences were observed between groups on POD 7. On regression analysis, IPACK block (β = −13.0; P = .03) and male sex (β = −9.9; P = .024) were significant negative predictors for opioid use on POD 1. The association of reduced opioid use in the IPACK group persisted on POD 2 (β = −12.0; P = .019) and POD 3 (β = −15.0; P < .001). Conclusion: The results of this study suggest that the addition of an IPACK block to an ACB leads to reduced opioid consumption, improved pain control, and higher satisfaction with pain control acutely after ACLR with a BTB autograft. Registration: NCT05286307 (ClinicalTrials.gov)

10 October 2023 in CARTILAGE
Verified
Journal Article
Open access
JTJairo Triana
Jairo Triana
NRNaina Rao
Naina Rao
MBMichael Buldo-Licciardi
Michael Buldo-Licciardi
ALAriana Lott
Ariana Lott
NRNicole D. Rynecki
Nicole D. Rynecki
KCKirk Anthony Campbell
Kirk Anthony Campbell
Objective: To evaluate the effect of fear of reinjury on return to sport (RTS), return to work (RTW), and clinical outcomes following autologous chondrocyte implantation (ACI). Design: A retrospective review of patients who underwent ACI with a minimum of 2 years in clinical follow-up was conducted. Patient-reported outcomes collected included the Visual Analog Scale (VAS) and Knee Injury and Osteoarthritis Outcome Score (KOOS). Kinesiophobia and pain catastrophizing was assessed using the Tampa Scale of Kinesiophobia-11 (TSK-11) and Pain Catastrophizing Scale (PCS), respectively. Patients were surveyed on their RTS and RTW status. Results: Fifty-seven patients (50.9% female) were included in our analysis. Twenty-two (38.6%) patients did not RTS. Of the 35 patients (61.4%) who returned, nearly half (48.6%) returned at a lower level of play. TSK-11 ( P = 0.003), PCS ( P = 0.001), and VAS pain scores ( P < 0.001) were significantly greater in patients that did not RTS than in those who returned. All KOOS subscores analyzed were significantly lower ( P < 0.001) in patients that did not RTS than in those who returned at the same level or higher. Of the 44 (77.2%) patients previously employed, 97.7% returned to work. Increasing TSK-11 scores were associated with lower odds of returning to sport ( P = 0.003). Conclusion: Fear of reinjury decreases the likelihood that patients will return to sport after ACI. Patients that do not return to sport report significantly greater levels of fear of reinjury and pain catastrophizing and lower clinical knee outcomes. Nearly all patients were able to return to work after surgery. Level of Evidence: IV case series.

1 July 2023 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
NRNaina Rao
Naina Rao
ZLZachary I Li
Zachary I Li
ALAriana Lott
Ariana Lott
NRNicole D. Rynecki
Nicole D. Rynecki
GGGuillem Gonzalez-Lomas
Guillem Gonzalez-Lomas
JTJairo Triana
Jairo Triana
Objectives: Expansion of chondral defect size and clinical outcomes in patients with cartilage lesions are thought to be modulated by several risk factors. Previous studies suggest that time delay until implantation may be a risk factor for an increase in the number and size of chondral lesions at the time of implantation. Reports on the effect of time delay on clinical outcomes, however, remain limited. Therefore, the purpose of this study was to evaluate the effect of time delay from cartilage biopsy to implantation on patient satisfaction, return to sport (RTS), and clinical outcomes following autologous chondrocyte implantation. Methods: A retrospective review was performed among patient who underwent autologous chondrocyte implantation (ACI) and matrix-associated autologous chondrocyte implantation (MACI) at a single institution between the years 2012 to 2020 with minimum 2-year clinical follow-up. Clinical outcomes were measured using the Visual Analog Scale (VAS) for pain and satisfaction and the Knee Injury and Osteoarthritis Outcome Score (KOOS; subscores: symptoms, pain, sport, and quality of life (QOL)). Time delay was calculated as the elapsed time between cartilage biopsy and implantation. Cartilage lesions were categorized based on the Outerbridge classification of chondral lesions. The number of high-grade lesions (Outerbridge grade 3 or 4) and size of lesions were analyzed at time of biopsy and implantation. T-tests or non-parametric tests and Chi-squared tests were used to analyze continuous variables and categorical variables, respectively. A one-way ANOVA was used to compare outcomes based on RTS status, using a post-hoc Tukey’s HSD test for multiple comparisons. Bivariate linear regression was used to determine the impact of the time interval from biopsy to implantation on the change in size of the largest high-grade lesion and RTS. Results: A total of 36 patients, mainly female (55.6%) aged 29.25 (± 9.49) with a mean follow-up of 6.51 ± 2.5 years were included in our analysis. Thirteen patients (36.1%) did not RTS. Of the 23 patients (63.9%) who returned to sport, 11 (30.6%) returned at their preoperative level or higher, and 12 (33.3%) returned at a lower level. VAS pain scores were significantly higher in patients who did not RTS vs those who did (42.85 vs. 9.35, p <0.001). All KOOS subscores (Symptom: 56.54 vs. 81.96, Pain: 72.22 vs. 91.74, Sports: 40.38 vs. 79.3, QOL: 35.58 vs. 70.38, p <0.001) were significantly lower in patients who did not RTS compared to those who returned. Increase in time delay from biopsy to implantation was associated with an increase in VAS pain score (OR [95% CI]; 1.42 [0.16 to 2.69], p=0.02) and inversely related to KOOS pain scores (OR [95% CI]; -1.01 [-1.83 to -0.01], p= 0.01. Furthermore, when comparing time from biopsy to implantation and expansion of the largest highgrade lesion, it was found that for every month increase in time, lesion surface area increased by 0.588 cm2; however, this correlation did not reach significance (p=0.09). The number of high-grade lesions at time of implantation were significantly higher in those that returned to sport at a lower level than those who did not return (1.67 vs. 1.23, p=0.02). The average surface area of the defect at biopsy and implantation were 3.13 cm2 and 4.38 cm2 respectively. The number of patients who had an increase in the number of high-grade lesions from biopsy to implantation was significantly higher in those who returned to sport at a lower level compared to those who did not return (4 vs. 1, p=0.05). Logistic regression demonstrated no significant relationship between time interval and rate of return to sport (p=3.59). No other associations were observed between time from biopsy to implantation and clinical outcomes. Conclusions: An increase in time delay from biopsy to graft implantation is associated with worse pain after surgery. Both the number of high-grade lesions at the time of implantation and an increase in time delay were not associated with lower rates of return to sport. Further studies are needed to evaluate the effects of time delay until implantation and its potential role as a risk factor for worse clinical outcomes in patients undergoing autologous chondrocyte implantation procedures. [Table: see text]

1 July 2023 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
JEJordan Eskenazi
Jordan Eskenazi
NRNaina Rao
Naina Rao
ZLZachary I Li
Zachary I Li
NRNicole D. Rynecki
Nicole D. Rynecki
SMSamuel Thomas Montgomery
Samuel Thomas Montgomery
MBMichael Buldo-Licciardi
Michael Buldo-Licciardi
Objectives: Prior studies report lower return to preinjury level of sport in patients who undergo bilateral anterior cruciate ligament (ACL) reconstructions compared to unilateral reconstructions, with the most common cited reason being fear of reinjury. The purpose of our investigation was to compare subsequent return rates and psychological readiness to return to sport (RTS) in patients who underwent bilateral versus unilateral ACL reconstructions. Methods: A retrospective review of patients who underwent ACL reconstruction at a single academic institution between 2012-2021 with a minimum of 1-year follow-up was conducted. Patients were divided into bilateral and unilateral cohorts. Those who underwent bilateral ACL reconstruction were matched 1:3 to unilateral reconstruction based on age, sex, BMI, and primary sport. Primary outcomes included return to sport, level of RTS and psychological readiness to RTS, assessed by the validated ACL- Return to Sport after Injury (ACL-RSI) scale. Within the ACL-RSI questionnaire, fear and confidence to return to sport were specifically analyzed. Fear to RTS was measured on a scale of 0-100 with 0 equal to extremely fearful and 100 equal to no fear at all. Confidence to RTS was measured on a scale of 0-100 with 0 equal to not at all confidence and 100 equal to fully confident. Statistical analysis was performed in R studio, with chi-square used for categorical values and two-sided t-test for continuous. Results: One hundred eighty-one patients were included, forty-three bilateral ACL reconstructions and one hundred thirty-eight unilateral. The unilateral cohort included 69 (50.0%) males and 69 (50.0%) females and the bilateral cohort included 22 (51.2%) males and 21 (48.8%) females. Mean age was 26.0 (14-56) in the unilateral cohort and 25.2 (14-50) in the bilateral cohort. Mean BMI was 25 (15.3-39.2) in the unilateral cohort and 28 (15.1-39.7[SM1] ) in the bilateral cohorts (p=.08). The percentage of individuals who returned to sport in the bilateral reconstruction cohort was not significantly different from those who returned in the unilateral cohort (79.6% vs 76.7%, p=0.85). There was no significant difference in psychological readiness to RTS (mean score 52.6 for bilateral and 47.4 for unilateral, p=0.31). There was also no significant difference between the level at which bilateral versus unilateral patients returned to sport. 59.6% unilateral returned to the same or higher level and 60.6% bilateral returned to the same or higher level, p=0.92. There was no significant difference in the reported scale of psychological readiness to return to sport (52.6 for bilateral and 47.4 for unilateral, p=0.31). When asked about fear to RTS, the mean scale response was 42.2 in the unilateral cohort and 46.5 in the bilateral (p=0.45). Conclusions: There is no difference in RTS and level of sport returned to between patients who undergo bilateral ACL reconstructions compared to patients who undergo unilateral ACL reconstructions. Psychological readiness, fear and confidence to return to sport were not different between unilateral and bilateral injuries.